Kehoe Law Firm, P.C. is investigating whether certain executive officers and directors of Revance Therapeutics, Inc. (“Revance” or the “Company”) (NASDAQ: RVNC) breached their fiduciary duties by failing to manage Revance in an acceptable manner and whether Revance and its shareholders were harmed as a result.
Key Issues Under Investigation
The investigation concerns whether Revance’s officers and directors made materially false and misleading statements or failed to disclose critical information regarding:
- Breach of the Distribution Agreement – Whether Revance materially breached its distribution agreement with Teoxane SA, thereby increasing the company’s risk of litigation; and
- Potential Delay or Amendment of the Tender Offer – Whether the Tender Offer, pursuant to a merger agreement with Crown Laboratories, Inc., was likely to be delayed or amended due to a breach of the distribution agreement.
Revance Stock Investors: Learn More About the Investigation and Your Legal Options
To learn more about the investigation or discuss potential legal claims, please send us a message or contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], for a free, no-obligation legal evaluation.
About Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is a multidisciplinary, plaintiff-side class action law firm specializing in securities fraud, breaches of fiduciary duties, and corporate misconduct. Collectively, the firm’s partners have served as Lead Counsel or Co-Lead Counsel in high-profile cases that have recovered more than $10 billion for both institutional and individual investors.
Our class action legal services are on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.
SEND US A MESSAGE
Contact Us
ADDRESS
Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103